EBC-1 Cells
CAD$1,104.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | EBC-1 is a human lung squamous cell carcinoma cell line, primarily noted for its relevance in studying mechanisms related to lung cancer, particularly non-small cell lung carcinoma (NSCLC). This cell line is characterized by MET gene amplification, which has been implicated in oncogenic signaling pathways that drive tumor growth and resistance to therapy. The MET receptor tyrosine kinase activation, typically induced by hepatocyte growth factor (HGF), plays a significant role in the proliferation, survival, and metastasis of these cells. Aberrations in MET signaling are pivotal in EBC-1’s aggressive tumor profile, making it an essential model for studying targeted therapies aimed at MET inhibition. Research utilizing EBC-1 cells has explored various resistance mechanisms to MET inhibitors, such as crizotinib. The cell line has demonstrated acquired resistance via pathways involving PAI-1 upregulation and epithelial-to-mesenchymal transition (EMT), contributing to therapeutic challenges. Additionally, sodium butyrate has been shown to modulate gene expression in EBC-1 cells, indicating the potential utility of histone deacetylase inhibitors in affecting gene transcription. These findings underscore the importance of EBC-1 in both therapeutic resistance research and the development of novel treatment strategies for MET-amplified lung cancers. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Squamous cell carcinoma |
| Metastatic site | Skin |
| Synonyms | EBC-1/original, EBC1 |
Characteristics
| Age | 69 years |
|---|---|
| Gender | Male |
| Ethnicity | Taiwanese |
| Growth properties | Adherent |
Regulatory Data
| Citation | EBC-1 (Cytion catalog number 305539) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2891 |
Biomolecular Data
| Mutational profile | Mutation: DDR2, p.Thr681Ile (c.2042C>T), heterozygous; Mutation: EGFR, p.Leu858Arg (c.2573T>G), heterozygous; Mutation: TP53, p.Glu171Ter (c.511G>T), homozygous |
|---|
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305539-300625 | Certificate of Analysis | 22. Oct. 2025 | 305539 |